This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.

The Northern Hemisphere is absorbing more sunlight than the Southern Hemisphere, and clouds can no longer keep the balance.

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Researchers have for the first time created a reconfigurable polariton 2D quasicrystal. The team from the Skolkovo Institute ...